/ Not yet recruitingPhase 2 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Lipid-Modifying Effect and Tolerability of MK-1903 in Patients with Dyslipidemia
100 Clinical Results associated with MSD Finland Oy
0 Patents (Medical) associated with MSD Finland Oy
100 Deals associated with MSD Finland Oy
100 Translational Medicine associated with MSD Finland Oy